Erratum: Corticosteroids for acute chest syndrome in children with sickle cell disease: Variation in use and association with length of stay and readmission (American Journal of Hematology (2010) DOI: 10.1002/ajh.21565);Corticosteroids for acute chest syndrome in children with sickle cell disease: Variation in use and association with length of stay and readmission

American Journal of Hematology

Volumn 85, Issue 1, 2010, Pages 24-28

  Sobota, Amy ^a,b,c,d   Graham, Dionne A ^a,c   Heeney, Matthew M ^a,b,c   Neufeld, Ellis J ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Harvard Pediatric Health Services Research Fellowship Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; DEXAMETHASONE; METHYLPREDNISOLONE; NITRIC OXIDE; OXYGEN; PREDNISOLONE; PREDNISONE;

ACUTE CHEST SYNDROME; ARTICLE; ASTHMA; CASE MIX; CHILD; CLINICAL EVALUATION; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DATA BASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; FEMALE; HOSPITAL; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MULTICENTER STUDY; PEDIATRICS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SICKLE CELL ANEMIA; ADOLESCENT; CLINICAL PRACTICE; FACTUAL DATABASE; PRESCHOOL CHILD; UNITED STATES;

ACUTE CHEST SYNDROME; ADOLESCENT; ADRENAL CORTEX HORMONES; ANEMIA, SICKLE CELL; ASTHMA; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HOSPITALS; HUMANS; LENGTH OF STAY; MALE; PATIENT READMISSION; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 74049124514     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21708     Document Type: Erratum

References (23)

1. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644.
2. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000;342:1855-1865.
3. Vichinsky E, Williams R, Das M, et al. Pulmonary fat embolism: A distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 1994; 83:3107-3112.
4. Styles LA, Aarsman AJ, Vichinsky EP, et al. Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood 2000; 96:3276-3278.
5. Bernini JC, Rogers ZR, Sandler ES, et al. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 1998;92:3082-3089.
6. Isakoff MS, Lillo JA, Hagstrom JN. A single-institution experience with treatment of severe acute chest syndrome: Lack of rebound pain with dexamethasone plus transfusion therapy. J Pediatr Hematol Oncol 2008;30:322-325.
7. Milner PF, Kraus AP, Sebes JI, et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 1991;325:1476-1481.
8. Darbari DS, Castro O, Taylor JGT, et al. Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease. J Natl Med Assoc 2008;100:948-951.
9. Strouse JJ, Hulbert ML, DeBaun MR, et al. Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics 2006;118:1916-1924.
10. Hughes J. 3M Health Information Systems (HIS) APRTM-Drug Classification Software Overview. Utah: 3M Health Information Systems; 2009.
11. Sedman AB, Bahl V, Bunting E, et al. Clinical redesign using all patient refined diagnosis related groups. Pediatrics 2004;114:965-969.
12. Joffe MM, Rosenbaum PR. Invited commentary: Propensity scores. Am J Epidemiol 1999;150:327-333.
13. Seeger JD, Kurth T, Walker AM. Use of propensity score technique to account for exposure-related covariates: An example and lesson. Med Care 2007;45:S143-S148.
14. Morris CR. Asthma management: Reinventing the wheel in sickle cell disease. Am J Hematol 2009;84:234-241.
15. Boyd JH, Macklin EA, Strunk RC, et al. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood 2006; 108:2923-2927.
16. Bacharier LB, Boner A, Carlsen KH, et al. Diagnosis and treatment of asthma in childhood: A PRACTALL consensus report. Allergy 2008;63:5-34.
17. Knapp JF, Simon SD, Sharma V. Quality of care for common pediatric respiratory illnesses in United States emergency departments: Analysis of 2005 National Hospital Ambulatory Medical Care Survey Data. Pediatrics 2008; 122:1165-1170.
18. McCormick MC, Kass B, Elixhauser A, et al. Annual report on access to and utilization of health care for children and youth in the United States, 1999. Pediatrics 2000;105:219-230.
19. Chandra D, Clark S, Camargo CA Jr. Race/ethnicity differences in the inpatient management of acute asthma in the United States. Chest 2009;135: 1527-1534.
20. Lantner R, Brennan RA, Gray L, et al. Inpatient management of asthma in the Chicago suburbs: The Suburban Asthma Management Initiative (SAMI). J Asthma 2005;42:55-63.
21. National Heart, Lung, and Blood Institute (NHLBI). 2007. Dexamethasone to treat acute chest syndrome in people with sickle cell disease. 〈http://clinicaltrials. gov/ct2/show/NCT00530270〉. Accessed June 19, 2009.
22. National Heart, Lung, and Blood Institute (NHLBI). 2008. Role of placenta growth factor in sickle acute chest syndrome. 〈http://www/clinicaltrials. gov/ ct2/show/NCT00448370〉. Accessed June 29, 2009.
23. Wallace KL, Marshall MA, Ramos SI, et al. NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-{gamma} and CXCR3 chemokines. Blood 2009;114:667-676.